- Report
- March 2025
- 193 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- September 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 178 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- December 2024
- 142 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- March 2024
- 119 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- November 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 130 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 137 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- December 2024
- 90 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- January 2024
- 179 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- September 2023
- 143 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- October 2023
- 431 Pages
Global
From €2377EUR$2,500USD£1,997GBP

The Renal Failure Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat renal failure, a condition in which the kidneys are unable to filter waste from the blood. These drugs are used to reduce the amount of waste in the blood, as well as to reduce the risk of complications associated with renal failure. Common drugs used to treat renal failure include diuretics, ACE inhibitors, and angiotensin receptor blockers. Additionally, drugs such as erythropoietin and iron supplements are used to treat anemia, a common complication of renal failure.
Some companies in the Renal Failure Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more